Deep Brain Stimulation Devices Market Size to Garner USD 2.80 Billion by 2026 | 15.5% CAGR

The Deep brain stimulation (DBS) devices market is a growing market that involves the use of implanted neurostimulation devices for the treatment of neurological and movement disorders, such as Parkinson's disease, essential tremor, and dystonia, among others. This market includes a variety of companies that offer DBS products and services, such as medical device manufacturers and healthcare providers.

The global deep brain stimulation devices market was valued at $881.9 million in 2018, and is projected to reach $2,802.6 million by 2026, registering a CAGR of 15.5%.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭@ https://www.alliedmarketresearch.com/request-sample/1477

The types of DBS devices available on the market include rechargeable and non-rechargeable devices, as well as directional and non-directional electrodes. These devices can be used to provide targeted stimulation to specific areas of the brain, improving symptoms and quality of life for patients with neurological and movement disorders.

With the growing prevalence of neurological disorders and the need for effective treatment options, the DBS devices market is expected to continue its growth trajectory in the coming years.

Increasing demand for minimally invasive surgery, adoption of technologically advanced products, and aging population drive the brain stimulation devices market as they are more susceptible to neurological disorders such as epilepsy, Parkinson's disease, Alzheimer's disease, and chronic pain. Increase in the prevalence of lifestyle diseases such as depression and chronic pain, increase in the number of neurological disorders and investment in neurological R&D are the factors driving the growth of the global deep brain stimulation devices market.

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝:

The Parkinson's disease segment captured the largest market share in 2018 and is expected to maintain this lead during the forecast period. Furthermore, the segment is expected to exhibit the fastest growth rate during the forecast period due to the increase in the prevalence of Parkinson's worldwide.

According to end-user, the hospital segment holds the highest deep brain stimulation device market share in 2018. In addition, this segment is expected to witness the fastest growth during the forecast period, as the number has increased. Hospitals around the world. Furthermore, neurological disorders are diagnosed and treated by professional neurologists using advanced equipment, which are available in specialized hospitals.

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟐𝟎𝟎 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬) @ https://www.alliedmarketresearch.com/deep-brain-stimulation-devices-market

North America accounted for the major share of the deep brain stimulation devices market size and is expected to continue this trend, owing to higher number of R&D activities, presence of skilled technicians, and wide availability of technologically advanced deep brain stimulation devices. Moreover, surge in prevalence of various neurological disorders is another factor that boost the deep brain stimulation devices market in the region.

𝐃𝐞𝐞𝐩 𝐁𝐫𝐚𝐢𝐧 𝐒𝐭𝐢𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

• Aleva Neurotherapeutics SA,
• Boston Scientific Corporation,
• Functional Neuromodulation Ltd.,
• Beijing PINS Medical Co., Ltd.,
• Medtronic plc,
• NeuroPace Inc.,
• Nevro Corporation,
• Neuronetics Inc.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲@ https://www.alliedmarketresearch.com/purchase-enquiry/1477

𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:

• This report entails a detailed quantitative analysis along with the current global deep brain stimulation devices market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
• The deep brain stimulation devices market forecast is studied from 2019 to 2026.

• The deep brain stimulation devices market size and estimations are based on a comprehensive analysis of key developments in the deep brain stimulation devices industry.
• A qualitative analysis based on innovative products facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲:

Gene Synthesis Market: https://www.alliedmarketresearch.com/gene-synthesis-market-A39015

Mobile Tomography Market: https://www.alliedmarketresearch.com/mobile-tomography-market-A31901

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.